(Q46397634)

21 December 2017

title

Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients (English)

1 reference

21 December 2017

1 reference

Tatiana S Rodriguez-Reyna

1

1 reference

21 December 2017

Andrea Hinojosa-Azaola

2

1 reference

21 December 2017

Cynthia Martinez-Reyes

3

1 reference

21 December 2017

Carlos A Nuñez-Alvarez

4

1 reference

21 December 2017

Rocío Torrico-Lavayen

5

1 reference

21 December 2017

José Luis García-Hernández

6

1 reference

21 December 2017

Javier Cabiedes-Contreras

7

1 reference

21 December 2017

publication date

30 August 2011

1 reference

21 December 2017

published in

Autoimmunity

1 reference

21 December 2017

volume

44

1 reference

21 December 2017

page(s)

576-584

1 reference

21 December 2017

issue

7

1 reference

21 December 2017

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

1 reference

Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Anti-U3 RNP autoantibodies in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

The genetics of scleroderma (systemic sclerosis).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Autoantibodies in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

The changing landscape of the clinical value of the PM/Scl autoantibody system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Scleroderma overlap syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Association of HLA class II genes with systemic sclerosis in Spanish patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2011.592886

10.3109/08916934.2011.592886

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

21875377

1 reference

21 December 2017